Praxis Precision Medicines Files 8-K
Ticker: PRAX · Form: 8-K · Filed: Apr 14, 2026
Sentiment: neutral
Topics: 8-K, routine-filing
TL;DR
Praxis Precision Medicines filed a standard 8-K, no major news.
AI Summary
On April 14, 2026, Praxis Precision Medicines, Inc. filed an 8-K report detailing other events. The filing does not contain specific financial figures or significant business updates beyond its routine reporting nature.
Why It Matters
This filing indicates routine corporate activity for Praxis Precision Medicines, Inc. It does not appear to contain material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report with no disclosed material events, financial changes, or significant business developments.
Key Players & Entities
- Praxis Precision Medicines, Inc. (company) — Filer of the 8-K report
- 0001689548 (company) — CIK number for Praxis Precision Medicines, Inc.
- 2026-04-14 (date) — Filing date of the 8-K report
FAQ
What type of report did Praxis Precision Medicines, Inc. file?
Praxis Precision Medicines, Inc. filed a Form 8-K, which is a current report.
When was the 8-K filing accepted by the SEC?
The 8-K filing was accepted on April 14, 2026, at 17:11:06.
What is the CIK number for Praxis Precision Medicines, Inc.?
The CIK number for Praxis Precision Medicines, Inc. is 0001689548.
What is the mailing and business address for Praxis Precision Medicines, Inc.?
The mailing and business address for Praxis Precision Medicines, Inc. is 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110.
What item is disclosed in this 8-K filing?
This 8-K filing discloses information under Item 8.01: Other Events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2026 regarding Praxis Precision Medicines, Inc. (PRAX).